With its Consumer Healthcare business managing to get back on par with the global market growth rate in 2021, Sanofi will be hoping for solid start to 2022 to cement the progress made over the past couple of years.
Fortunately the Paris-based firm could not wish for a much more favorable comparative when it reports its Q1 results on...







